BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 22484189)

  • 1. Advances in the systemic treatment of cutaneous sarcomas.
    Luke JJ; Keohan ML
    Semin Oncol; 2012 Apr; 39(2):173-83. PubMed ID: 22484189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in salvage chemotherapy for patients with metastatic soft tissue sarcoma.
    Hartmann JT; Patel S
    Drugs; 2005; 65(2):167-78. PubMed ID: 15631540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines.
    Hartmann JT
    Anticancer Drugs; 2007 Mar; 18(3):245-54. PubMed ID: 17264755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and advancing systemic treatment options for soft tissue sarcomas.
    Harris SJ; Benson C; Jones RL
    Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apatinib as targeted therapy for advanced bone and soft tissue sarcoma: a dilemma of reversing multidrug resistance while suffering drug resistance itself.
    Yang QK; Chen T; Wang SQ; Zhang XJ; Yao ZX
    Angiogenesis; 2020 Aug; 23(3):279-298. PubMed ID: 32333216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olaratumab for the treatment of soft tissue sarcoma.
    Deshpande HA; Cecchini M; Ni Choileain S; Jones R
    Drugs Today (Barc); 2017 Apr; 53(4):247-255. PubMed ID: 28492292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histology-Specific Uses of Tyrosine Kinase Inhibitors in Non-gastrointestinal Stromal Tumor Sarcomas.
    Sethi TK; Keedy VL
    Curr Treat Options Oncol; 2016 Feb; 17(2):11. PubMed ID: 26931561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel targeted therapies in the treatment of soft-tissue sarcomas.
    Chao J; Chow WA; Somlo G
    Expert Rev Anticancer Ther; 2010 Aug; 10(8):1303-11. PubMed ID: 20735315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant and neoadjuvant chemotherapy for soft tissue sarcomas: JCOG Bone and Soft Tissue Tumor Study Group.
    Tanaka K; Ozaki T
    Jpn J Clin Oncol; 2021 Feb; 51(2):180-184. PubMed ID: 33313851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma.
    Martin-Liberal J; Pérez E; García Del Muro X
    Expert Opin Investig Drugs; 2019 Jan; 28(1):39-50. PubMed ID: 30513001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy in bone and soft tissue sarcoma in children and adolescents.
    Thompson PA; Chintagumpala M
    Curr Oncol Rep; 2012 Apr; 14(2):197-205. PubMed ID: 22302601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cabozantinib as an emerging treatment for sarcoma.
    Schöffski P; Blay JY; Ray-Coquard I
    Curr Opin Oncol; 2020 Jul; 32(4):321-331. PubMed ID: 32541320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic applications of histone deacetylase inhibitors in sarcoma.
    Tang F; Choy E; Tu C; Hornicek F; Duan Z
    Cancer Treat Rev; 2017 Sep; 59():33-45. PubMed ID: 28732326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting angiogenesis for the treatment of sarcoma.
    Balasubramanian L; Evens AM
    Curr Opin Oncol; 2006 Jul; 18(4):354-9. PubMed ID: 16721130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas.
    Heymach JV; Desai J; Manola J; Davis DW; McConkey DJ; Harmon D; Ryan DP; Goss G; Quigley T; Van den Abbeele AD; Silverman SG; Connors S; Folkman J; Fletcher CD; Demetri GD
    Clin Cancer Res; 2004 Sep; 10(17):5732-40. PubMed ID: 15355900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcoma.
    Maki R
    Oncologist; 2001; 6(4):333-7. PubMed ID: 11524551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soft tissue sarcomas in skin: presentations and management.
    Patt JC; Haines N
    Semin Oncol; 2016 Jun; 43(3):413-8. PubMed ID: 27178697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pazopanib, a new therapy for metastatic soft tissue sarcoma.
    Verweij J; Sleijfer S
    Expert Opin Pharmacother; 2013 May; 14(7):929-35. PubMed ID: 23488774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials.
    Tang F; Tie Y; Wei YQ; Tu CQ; Wei XW
    Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188606. PubMed ID: 34371128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating soft tissue sarcomas with adjuvant chemotherapy.
    Patrikidou A; Domont J; Cioffi A; Le Cesne A
    Curr Treat Options Oncol; 2011 Mar; 12(1):21-31. PubMed ID: 21384115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.